Stay updated on IO-202 in AML/CMML Clinical Trial
Sign up to get notified when there's something new on the IO-202 in AML/CMML Clinical Trial page.

Latest updates to the IO-202 in AML/CMML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Updated operating status notice due to funding lapse and guidance to official status pages. - Version bumped from v3.1.0 to v3.2.0.SummaryDifference3%
- Check18 days agoChange Detected- Core page content: version updated from v3.0.2 to v3.1.0. - No other substantive content changes indicated. If this is a product page, it signals a software release rather than content changes.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a PubMed-listed Publications entry for IO-202 (phase 1 study) and updated to v3.0.2; removed the old v3.0.1 revision and the Back to Top link.SummaryDifference4%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of various chemical compounds related to azacitidine and venetoclax. Notably, previous references to specific diseases and certain location details have been removed.SummaryDifference3%
- Check54 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.7%
Stay in the know with updates to IO-202 in AML/CMML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO-202 in AML/CMML Clinical Trial page.